Pharmagreen Biotech Inc. Overview
Pro stress-test →Pharmagreen Biotech Inc. operates as a nutraceutical company, engaging in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body.
Strategic Profile
Pro stress-test →The company also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. As of October 2024, Pharmagreen is developing a specialized form of cannabis oil known as Live Rosin, a highly sought-after cannabis concentrate recognized for its unmatched purity, potency, and rich flavor profile.
Competitive Landscape
Pro stress-test →Pharmagreen competes in fragmented nutraceutical and botanical supplement markets alongside larger diversified consumer health companies (e.g., GNC, Nature's Way, Gaia Herbs) and specialized mushroom supplement brands (e.g., Four Sigmatic, Mycotech Labs). In cannabis extraction and processing, it would compete against established licensed producers and extractors in regulated jurisdictions. Limited scale, brand recognition, and OTC regulatory constraints constrain competitive positioning relative to established public biotech and supplement firms.
Industry Context
Pharmagreen Biotech Inc. operates in Nutraceutical supplements and botanical extracts.
Key facts
Founded: N/A · Headquarters: Coquitlam, Canada · Employees: N/A · Revenue: N/A · Market cap: $1.92M